TNF Pharmaceuticals, Inc. reported on September 2, 2025, that it will raise $7,000,000 by issuing 7,000 shares of convertible preferred stock and accompanying warrants, convertible into up to 1.4 million common shares at $5.00 each, to accredited investors.